Metoprolol Sustained-Release Coating Eliminates Lag Phase
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current sustained-release compositions of metoprolol succinate and hydrochlorothiazide face challenges with delayed drug release due to complex coating formulations and the use of water-insoluble coatings, leading to suboptimal therapeutic effects.
Innovation Solution
A sustained-release composition comprising metoprolol with a blank pellet core, an active constituent layer, and a sustained-release coating layer using ethyl cellulose and a pore-forming agent like hydroxypropyl cellulose, which allows for controlled drug release, eliminating the lag phase and enhancing bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If water-insoluble coating is used as coating material to prepare sustained-release pellet, then film-forming property is improved, but permeability deteriorates, resulting in delayed drug release
Solution Approach 1:
The coating layer uses a composite formulation combining water-insoluble materials (ethyl cellulose, hydroxypropyl methyl cellulose acetate succinate) with water-soluble pore-forming agents (hydroxypropyl cellulose, polyvinylpyrrolidone). This composite approach maintains the film-forming strength of water-insoluble materials while introducing controlled permeability through the water-soluble components that create pores during dissolution.
Solution Approach 2:
The coating layer incorporates pore-forming agents (hydroxypropyl cellulose at 5-15% and polyvinylpyrrolidone at 5-15%) that create a porous structure. These pores allow controlled water penetration and drug diffusion, transforming the dense water-insoluble coating into a permeable matrix that enables sustained drug release without compromising film integrity.
2Reliability
If traditional hydrophilic polymer material is used as pore-forming agent, then drug release is enabled, but lagging phase occurs at early stage of drug release
Solution Approach 1:
The invention merges water-insoluble coating materials with water-soluble pore-forming agents in a single integrated coating layer. This combination allows simultaneous achievement of film-forming property and permeability, eliminating the need for separate coating steps and preventing the lagging phase by ensuring immediate drug release capability from the coated pellets.
Solution Approach 2:
The coating formulation optimizes the proportions of different components (ethyl cellulose 70-85%, hydroxypropyl methyl cellulose acetate succinate 10-20%, hydroxypropyl cellulose 5-15%, polyvinylpyrrolidone 5-15%) to achieve the desired balance between film strength and permeability. This parameter optimization ensures rapid onset of drug release without lagging phase while maintaining sustained release characteristics.
3Reliability
If complex coating formula is used, then sustained-release effect is achieved, but manufacturing complexity increases
Solution Approach 1:
The invention establishes specific concentration ranges for each coating component (ethyl cellulose 70-85%, hydroxypropyl methyl cellulose acetate succinate 10-20%, pore-forming agents 5-15% each) that optimize the sustained-release effect. These standardized parameter ranges simplify manufacturing by providing clear formulation guidelines while ensuring reliable drug release profiles.
Solution Approach 2:
The coating layer uses a composite formulation combining water-insoluble materials (ethyl cellulose, hydroxypropyl methyl cellulose acetate succinate) with water-soluble pore-forming agents (hydroxypropyl cellulose, polyvinylpyrrolidone). This composite approach maintains the film-forming strength of water-insoluble materials while introducing controlled permeability through the water-soluble components that create pores during dissolution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves a stable and ideal drug-release profile with increased bioavailability, reducing the time to peak concentration and ensuring nearly complete drug release within 20 hours, compared to traditional preparations.
Implementation Method 1
a sustained-release coating layer using ethyl cellulose and a pore-forming agent like hydroxypropyl cellulose, which allows for controlled drug release
Implementation Method 2
ensuring nearly complete drug release within 20 hours
Implementation Method 3
a sustained-release coating layer using ethyl cellulose and a pore-forming agent like hydroxypropyl cellulose
Data Source
AI summary
The invention relates to a drug sustained-release composition, particularly a sustained-release composition comprising metoprolol and preparation method thereof. The invention also relates to a combination product comprising a sustained-release composition comprising metoprolol and a pharmaceutical composition comprising hydrochlorothiazide. The sustained-release composition comprising metoprolol according to the invention eliminates the phenomena of delayed release of such sustained-release compositions in the prior art, has a better drug release curve, and also have the advantages such as simple formula, easy operation, stable quality, strong controllability, and good reproducibility, and therefore have good application prospects.